A 26-year-old woman with PCOD presents with menstrual irregularity and infertility. Her pelvic ultrasound shows bilateral polycystic ovaries. Which single ultrasound or clinical finding best distinguishes PCOD from secondary polycystic ovarian morphology (PCOM) seen in other endocrine disorders?

Explanation

## Distinguishing PCOD from Secondary PCOM ### Morphology vs. Syndrome **Key Point:** Polycystic ovarian morphology (PCOM) — the ultrasound finding of multiple small follicles — is **necessary but NOT sufficient** for PCOD diagnosis. PCOM can occur in other endocrine disorders (Cushing syndrome, hyperprolactinaemia, thyroid disease). **True PCOD requires clinical and biochemical features in addition to morphology.** ### Rotterdam Criteria (2003) for PCOD Diagnosis Diagnosis requires **≥2 of 3 criteria:** 1. **Oligo- or anovulation** (menstrual irregularity, infertility) 2. **Clinical or biochemical hyperandrogenism** (hirsutism, acne, elevated testosterone) 3. **Polycystic ovarian morphology** (≥12 follicles per ovary OR increased ovarian volume >10 cm³) **Exclusion of other causes** (Cushing, hyperprolactinaemia, thyroid disease, 21-OH deficiency) is mandatory. ### Comparison Table: PCOD vs. Secondary PCOM | Feature | PCOD | Secondary PCOM (e.g., Cushing, Hyperprolactinaemia) | | --- | --- | --- | | **Ultrasound morphology** | Bilateral polycystic ovaries | Bilateral polycystic ovaries (indistinguishable) | | **Stromal echogenicity & volume** | **Increased** | May be normal or increased | | **Clinical hyperandrogenism** | **Present (hirsutism, acne)** | **Absent or mild** | | **Menstrual dysfunction** | **Oligo-/anovulation** | **Amenorrhoea from hyperprolactinaemia or cortisol excess** | | **LH:FSH ratio** | **Elevated (>3:1)** | Normal | | **Biochemical markers** | Elevated testosterone, normal ACTH/prolactin | Abnormal ACTH/cortisol or elevated prolactin | | **Reversibility** | Persistent | **Reverses with treatment of underlying disorder** | ### Clinical Pearl **Clinical Pearl:** The **combination of polycystic ovarian morphology + clinical hyperandrogenism + ovulatory dysfunction + exclusion of secondary causes** is what distinguishes true PCOD from incidental PCOM. A woman with Cushing syndrome may have polycystic-looking ovaries on ultrasound, but she will lack clinical hirsutism and will have suppressed cortisol on dexamethasone suppression test. ### High-Yield Concept **High-Yield:** PCOM is a **morphological finding**; PCOD is a **clinical syndrome**. Many women have PCOM without PCOD (asymptomatic, normal androgens, regular cycles). Conversely, some women with PCOD may not have classic PCOM on ultrasound (lean PCOD phenotype). ### Why Option 1 (Elevated Stromal Echogenicity + Clinical Hyperandrogenism + Ovulatory Dysfunction) Is the Best Discriminator This option captures the **syndrome** rather than just morphology: - **Increased stromal echogenicity and volume** are features of true PCOD (reflects androgen-driven stromal proliferation) - **Clinical hyperandrogenism** (hirsutism, acne) is present in PCOD but absent in secondary PCOM - **Ovulatory dysfunction** (oligo-/anovulation) is the functional consequence of PCOD, whereas secondary PCOM may present with amenorrhoea from a different mechanism (hyperprolactinaemia, cortisol excess) Together, these distinguish PCOD from PCOM secondary to other endocrine disorders. [cite:Rotterdam ASRM/ESHRE Consensus 2003; Yen & Jaffe's Reproductive Endocrinology 8e Ch 31]